AlphaCrest Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,597
| Closed | -$511K | – | 1205 |
|
|
2020
Q3 | $511K | Buy |
+8,597
| New | +$511K | 0.06% | 572 |
|
|
2020
Q2 | – | Sell |
-5,806
| Closed | -$263K | – | 1017 |
|
|
2020
Q1 | $263K | Buy |
+5,806
| New | +$263K | 0.03% | 842 |
|
|
2019
Q4 | – | Sell |
-6,160
| Closed | -$383K | – | 1315 |
|
|
2019
Q3 | $383K | Buy |
+6,160
| New | +$383K | 0.02% | 1031 |
|
|
2019
Q2 | – | Sell |
-3,597
| Closed | -$282K | – | 1087 |
|
|
2019
Q1 | $282K | Buy |
+3,597
| New | +$282K | 0.04% | 675 |
|